2026-10-19T01:02:58Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/170982026-10-18T20:49:51Zopenairedrivercom_ebyu_10000col_ebyu_10001

Management of Chronic Hepatitis B in Special Patient Groups: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023Tekin, SuedaKarakecili, FarukBinay, Umut DevrimCelik, IlhamiTulek, NeclaTutuncue, EdizYildiz, OrhanYilmaz, EmelDemirturk, NeseChronic hepatitis Bspecial patient groupstherapyACUTE LIVER-FAILURETENOFOVIR DISOPROXIL FUMARATEACTING ANTIVIRAL THERAPYVIRUS INFECTIONC VIRUSNUCLEOS(T)IDE ANALOGSLAMIVUDINE TREATMENTFULMINANT-HEPATITISHBV/HCV COINFECTIONADEFOVIR DIPIVOXILMedicine, General & InternalMicrobiologyGeneral & Internal MedicineTurkish Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Working Group updated the consensus report on the management of chronic hepatitis B (CHB) in private hosts and special situations. Relevant literature and international guidelines are reviewed, and agreed recommendations are presented at the end of each chapter. In the report, treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection, management of HBV and hepatitis C virus (HCV) coinfection, management of CHB in severe COVID-19 patients, non-transplant immunocompromised patients.DOC DESIGN & INFORMATICS CO LTD2023Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/17098https://doi.org/10.36519/kd.2023.46841301-143XenKLIMIK JOURNALinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/17098